Market closedNon-fractional
Medifast/MED
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Medifast
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
Ticker
MED
Sector
Consumer Non-Cyclicals
Trading on
NYSE
Industry
Personal Care Products
Headquarters
Baltimore, United States
Employees
634
Website
medifastinc.com
Medifast Metrics
BasicAdvanced
$209M
Market cap
3.15
P/E ratio
$6.19
EPS
1.15
Beta
$3.30
Dividend rate
16.90%
Dividend yield
Price and volume
Market cap
$209M
Beta
1.15
Dividend rate
$3.30
Financial strength
Current ratio
2.845
Quick ratio
2.027
Long term debt to equity
6.926
Total debt to equity
9.75
Dividend payout ratio (TTM)
80.52%
Management effectiveness
Return on assets (TTM)
16.44%
Return on equity (TTM)
35.49%
Valuation
Price to earnings (TTM)
3.154
Price to revenue (TTM)
0.237
Price to book
0.97
Price to tangible book (TTM)
0.97
Price to free cash flow (TTM)
2.513
Dividend yield (TTM)
16.90%
Growth
Revenue change (TTM)
-41.32%
Earnings per share change (TTM)
-51.56%
3-year revenue growth (CAGR)
-6.46%
3-year earnings per share growth (CAGR)
-16.35%
3-year dividend per share growth (CAGR)
-11.80%
What the Analysts think about Medifast
Analyst Ratings
Majority rating from 2 analysts.
Medifast Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$175M
-8.53%
Net income
$8.3M
38.33%
Profit margin
4.75%
51.27%
Medifast Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.77
$2.12
$0.55
$0.66
-
Expected
$1.44
$1.07
$0.96
$0.78
$0.33
Surprise
92.36%
99.06%
-42.71%
-15.38%
-
Medifast News
AllArticlesVideos
Investor Participation Is Invited As The Schall Law Firm Announces An Investigation Into Claims Against Medifast, Inc.
Accesswire·3 weeks ago
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
Accesswire·3 months ago
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm
Accesswire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Medifast stock?
Medifast (MED) has a market cap of $209M as of July 26, 2024.
What is the P/E ratio for Medifast stock?
The price to earnings (P/E) ratio for Medifast (MED) stock is 3.15 as of July 26, 2024.
Does Medifast stock pay dividends?
Yes, the Medifast (MED) stock pays dividends to shareholders. As of July 26, 2024, the dividend rate is $3.3 and the yield is 16.9%. Medifast has a payout ratio of 80.52% on a trailing twelve-month basis.
When is the next Medifast dividend payment date?
The next Medifast (MED) dividend payment date is unconfirmed.
What is the beta indicator for Medifast?
Medifast (MED) has a beta rating of 1.15. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Medifast stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.